Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
Samsung BioLogics confirmed Thursday morning that it will officially pursue an initial public offering on South Korea’s main bourse KOSPI.
The decision will be confirmed at the company’s board meeting today, which starts at 9 a.m., Korean time. The firm will reveal the specific details of its scheduled IPO after the meeting concludes.
By Sohn Ji-young (jys@heraldcorp.com)
